Related Experiment Video
Updated: Jan 29, 2026

12:03
Preparation of Mica and Silicon Substrates for DNA Origami Analysis and Experimentation
Published on: July 23, 2015
15.0K
Association Between Amino Acid Polymorphisms in MICA and MICA-NKG2D Interaction Affinity: Implications and
Chuyu Xiao1, Wang Wang1, Yangyang Zhang1
1Department of Immunology, School of Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Biomolecules
|January 28, 2026
Summary
Major histocompatibility complex class I-related gene A (MICA) polymorphism impacts NKG2D binding, influencing anti-tumor immunity. This interaction
Area of Science:
- Immunology
- Genetics
- Oncology
Background:
- Major histocompatibility complex class I-related gene A (MICA) is a highly polymorphic gene.
- MICA is expressed on tumor cells and interacts with activating receptors on immune cells like NK cells.
- MICA-NKG2D interactions are crucial for anti-tumor immune responses.
Purpose of the Study:
- To review the impact of MICA amino acid polymorphism on NKG2D pathway affinity.
- To analyze the role of MICA polymorphism in tumor immunity.
- To provide a basis for MICA-NKG2D targeted anti-tumor therapies.
Main Methods:
- Literature review on MICA polymorphism and NKG2D interactions.
- Analysis of MICA's role in tumor immunity.
- Examination of MICA-NKG2D signaling in anti-tumor responses.
Main Results:
- MICA amino acid polymorphisms significantly affect MICA-NKG2D binding affinity.
- MICA-NKG2D binding strength influences NK cell anti-tumor effects and patient prognosis.
- Strong MICA-NKG2D interactions can lead to negative feedback, down-regulating immune responses.
Conclusions:
- Evaluating anti-tumor immunity solely based on MICA-NKG2D binding affinity has limitations.
- Understanding MICA polymorphism's role in tumor immunity is essential.
- The MICA-NKG2D axis offers potential for future anti-tumor immunotherapies.
More Related Videos
Related Concept Videos
Amino acids
105.2K
Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
105.2K
Amino Acid Catabolism
1.1K
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
1.1K
Affinity and Avidity
38.7K
Overview
38.7K
Amino Acid Biosynthetic Pathways
1.2K
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.2K
Electron Affinity
43.3K
The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.3K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
935
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
935

